Podcast Episodes

Can cell therapy tackle hearing loss?

Hearing loss is a huge – and growing – global challenge.

Using its OSPREY platform, UK-based Rinri Therapeutics is developing a portfolio of off-the-s…

2 years, 4 months ago

How biotech is tackling myasthenia gravis

June is myasthenia gravis awareness month. Myasthenia gravis is a chronic autoimmune disorder where antibodies destroy the communication between nerv…

2 years, 4 months ago

Antisense oligonucleotides

German-headquartered Isarna Therapeutics is developing a portfolio of antisense therapies targeting an emerging therapeutic field in human biology – …

2 years, 5 months ago

Making waves in cardiovascular disease treatment

Cytokinetics is a late-stage, specialty cardiovascular biopharmaceutical company focused on discovering, developing and commercializing first-in-clas…

2 years, 5 months ago

New ways to treat Duchenne muscular dystrophy

Duchenne muscular dystrophy (DMD) is a genetic disorder with progressive muscle degeneration and weakness due to changes in the protein dystrophin, w…

2 years, 5 months ago

Overcoming clinical trial challenges

This week, we have a conversation about clinical trial design with Gen Li, the president and founder of Phesi, a global provider of patient-centric d…

2 years, 5 months ago

The biotech investment landscape in 2024

RTW is a global multi-strategy investment firm focused on supporting innovative biotech and biopharma companies across the US, Europe, and China. 

The…

2 years, 5 months ago

Redefining chronic pain treatment

Doloromics is a precision neuropharmaceuticals company. It was set up four years ago, to use newer technologies, particularly in the omics space, to …

2 years, 6 months ago

Colossal aims to bring back mammoth by 2028

Based in Austin, Texas, biotech Colossal Biosciences is at the forefront of de-extinction, critically endangered species protection and the repopulat…

2 years, 6 months ago

New treatments being developed for schizophrenia

It would appear that 2024 is shaping up to be a big year for the development of treatments for schizophrenia, with several clinical trials under way.…

2 years, 6 months ago